No credit card. No commitment.
5000+ G2 reviews
Duet BioTherapeutics
Research
Founded in 2019
Los Angeles, California
duettx.comDuet BioTherapeutics
ResearchFounded in 2019Los Angeles, California
EmployeesDuet BioTherapeutics' financial review
Employees
3
Total Funding
229.9K
Last Funding Round
229.9K
Duet BioTherapeutics information
Duet BioTherapeutics is an immunotherapy company creating a new category of bispecific oligonucleotide treatments designed to target dormant immune cells within the tumor microenvironment. Activation of these antigen-presenting cells removes the immunosuppressive shield around the tumor and jump-starts T cell-mediated immune responses to kill cancer cells.
Duet BioTherapeutics industries
Immunooncology
Immunotherapy
Oligonucleotides
Research
Duet BioTherapeutics' financial review
Employees
3
Total Funding
229.9K
Last Funding Round
229.9K
Employee Metrics
Technologies
Domain Name Services
Email Providers
Hosting
Fonts
Analytics and Tracking
Notable Alumni
Employees
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
